Paper
N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
Published 2001 · S. Chung, D. Kim
Bioorganic & medicinal chemistry
Q2 SJR score
14
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
N-(Hydroxyaminocarbonyl)phenylalanine is a novel inhibitor for carboxypeptidase A, with the d-configuration being more potent than its antipode by about 3-fold.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
d-Stereospecificity in the inhibition of thermolysin by N-acyl-N-hydroxy-α-amino acid esters
N-acyl-N-hydroxy--amino acid esters show d-stereospecificity in inhibiting thermolysin, with their inhibitory potency decreasing as the alkyl group in the hydroxamate moiety becomes bulkier.
1997·4citations·Yonghao Jin et al.·Tetrahedron-asymmetry
Tetrahedron-asymmetry
Matrilysin-inhibitor complexes: common themes among metalloproteases.
The crystal structures of human matrilysin reveal the dominant role of the zinc-coordinating group in determining the relative potencies of inhibitors targeting metalloproteases.
1996·201citations·M. Browner et al.·Biochemistry
Biochemistry
Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase
Kelatorphan and related analogs are potent and selective inhibitors of leukotriene A4 hydrolase, effectively inhibiting both hydrolase and aminopeptidase activities.
1995·31citations·T. Penning et al.·Bioorganic & Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters
Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.
Hydroxamates with novel heteroatom-based modifications of the P1' group effectively inhibit matrix metalloproteinases, potentially revealing their roles in normal and disease states.
1995·44citations·Madhusudhan R. Gowravaram et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors.
The hydroxamic derivatives of 1,2-cyclomethylenecarboxylic acid show potential as a novel class of non-amino acid angiotensin converting enzyme inhibitors, meeting the enzyme's binding requirements.
1993·42citations·L. Turbanti et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
The first mechanism-based inactivators for angiotensin-converting enzyme.
The first mechanism-based inactivator for angiotensin-converting enzyme (ACE) is N-[N-(cyanoacetyl)-L-phenylalanyl]-L-phenylalanine (compound 1).
1992·12citations·S. S. Ghosh et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
A novel series of N-[(2-benzothiazolylthio)alkyl]-N'-hydroxyurea derivatives (9-25) shows oral activity as inhibitors of 5-lipoxygenase, with some showing in vivo activity.
1992·16citations·M. Greco et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Hydroxamic acid inhibitors of 5-lipoxygenase.
Hydroxamic acid inhibitors can be effectively selected by matching their structures to the enzyme's geometry, resulting in some of the most potent inhibitors reported to date.
1987·78citations·J. Summers et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Citations
Mode of Metal Ligation Governs Inhibition of Carboxypeptidase A
The strength of inhibitory effect on carboxypeptidase A is not related to binding strength, but rather due to blocking a coordination site at the Zn ion by ligands coordinating metal ions in a bidentate fashion.
2024·0citations·Jorge Antonio Amador Balderas et al.·International Journal of Molecular Sciences
International Journal of Molecular Sciences
Metallocarboxypeptidases and their inhibitors: recent developments in biomedically relevant protein and organic ligands.
Recent research on metallocarboxypeptidase inhibitors, particularly small molecular weight inhibitors, has led to new drug designs in the cardiovascular field.
2013·19citations·D. Fernández et al.·Current medicinal chemistry
Current medicinal chemistry
Progress in metallocarboxypeptidases and their small molecular weight inhibitors.
Metallocarboxypeptidases (MCPs) have become key players in cellular and molecular processes, with promising advances in the discovery and design of small molecular weight inhibitors, but specificity and oral bioavailability remain challenges.
2010·43citations·D. Fernández et al.·Biochimie
Biochimie
High Enrichment of MMP-9 and Carboxypeptidase A by Tweezing Adsorptive Bubble Separation (TABS)
Tweezing adsorptive bubble separation (TABS) effectively enriches zinc-containing proteases MMP-9 and CPA without significant loss of enzymatic activity.
2010·5citations·D. Haller et al.·Applied Biochemistry and Biotechnology
Applied Biochemistry and Biotechnology
Asymmetric synthesis of N-substituted N-hydroxyureas
Asymmetric synthesis of N-substituted N-hydroxyureas, lipoxygenase inhibitors, can be achieved using three approaches, with enantioselective reduction of oximes or primary amines resulting in 57% to 99% ee conversion.
2008·16citations·Krzysztof Z Łączkowski et al.·Tetrahedron-asymmetry
Tetrahedron-asymmetry